Starcoin Group Limited

SEHK:399 Stock Report

Market Cap: HK$450.0m

Starcoin Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ming Wu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure3yrs
Board average tenure4.8yrs

Recent management updates

Recent updates

We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability

Jan 03
We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability

Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?

Aug 12
Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?

Robust Earnings May Not Tell The Whole Story For Innovative Pharmaceutical Biotech (HKG:399)

Jan 05
Robust Earnings May Not Tell The Whole Story For Innovative Pharmaceutical Biotech (HKG:399)

Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?

Feb 18
Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?

Innovative Pharmaceutical Biotech's(HKG:399) Share Price Is Down 80% Over The Past Five Years.

Nov 26
Innovative Pharmaceutical Biotech's(HKG:399) Share Price Is Down 80% Over The Past Five Years.

CEO

Ming Wu (46 yo)

less than a year
Tenure

Dr. Ming Wu is Executive Director of Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited) from April 7, 2025 and serves as its Chief Executive Officer since July 17, 2025. H...


Leadership Team

NamePositionTenureCompensationOwnership
Yung Yeung
Executive Chairmanless than a yearno datano data
Rong Tang
Executive Director11.2yrsHK$548.00k0.018%
HK$ 83.2k
Yuan Xing Gao
Executive Director9.8yrsHK$1.36mno data
Shujuan Qi
Executive Directorless than a yearno datano data
Ming Wu
CEO & Executive Directorless than a yearno datano data
Yumin Mao
Honorary Chairman & Chief Scientific Adviser5.2yrsno data17.07%
HK$ 76.8m
Hon Yin Poon
Financial Controller & Company Secretary12.5yrsno datano data
Peilun Li
Chief Technology Officerless than a yearno datano data
Qi Dong
Sales Head of the Groupno datano datano data
Wei Yu
Joint Chairman to the Department of Innovation & Strategic Development and Advisorno datano datano data
Jie Gu
Adviser and Joint Chairman to the Department of Innovation & Strategic Development9.9yrsno datano data
Long Fan
Executive Directorless than a yearno datano data
3.0yrs
Average Tenure
59yo
Average Age

Experienced Management: 399's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yung Yeung
Executive Chairmanless than a yearno datano data
Rong Tang
Executive Director11.2yrsHK$548.00k0.018%
HK$ 83.2k
Yuan Xing Gao
Executive Director9.8yrsHK$1.36mno data
Shujuan Qi
Executive Directorless than a yearno datano data
Ming Wu
CEO & Executive Directorless than a yearno datano data
Yumin Mao
Honorary Chairman & Chief Scientific Adviser15.2yrsno data17.07%
HK$ 76.8m
Long Fan
Executive Directorless than a yearno datano data
Shen Zhang
Executive Directorless than a yearno datano data
Dong Hui
General Manager of the Group and Director of CJVno datano datano data
Weijun Chen
Independent Non-Executive Director16yrsHK$80.00kno data
Rongliang Wang
Independent Non-Executive Director14.4yrsHK$60.00kno data
Jinzhong Chen
Independent Non-Executive Director4.8yrsHK$60.00kno data
4.8yrs
Average Tenure
63yo
Average Age

Experienced Board: 399's board of directors are considered experienced (4.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/08 23:37
End of Day Share Price 2025/11/07 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Starcoin Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.